162 related articles for article (PubMed ID: 11236608)
21. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
[TBL] [Abstract][Full Text] [Related]
22. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
Masaoka T
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
[No Abstract] [Full Text] [Related]
23. Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
Contreras V; Sepúlveda S; Heredia A
Medwave; 2016 Feb; 16 Suppl 1():e6379. PubMed ID: 26938974
[TBL] [Abstract][Full Text] [Related]
24. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
[No Abstract] [Full Text] [Related]
25. A nurse-led protocol improves the time to first dose intravenous antibiotics in septic patients post chemotherapy.
Mattison G; Bilney M; Haji-Michael P; Cooksley T
Support Care Cancer; 2016 Dec; 24(12):5001-5005. PubMed ID: 27455849
[TBL] [Abstract][Full Text] [Related]
26. Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.
Young LS; Meyer-Dudnik PV; Hindler J; Martin WJ
J Antimicrob Chemother; 1981 Jul; 8 Suppl A():121-32. PubMed ID: 7263559
[No Abstract] [Full Text] [Related]
27. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
Rolston KV
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
[TBL] [Abstract][Full Text] [Related]
28. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
[TBL] [Abstract][Full Text] [Related]
29. [Empirical treatment of febrile episodes in patients with neutropenia in bone marrow transplantation].
Pérez M; Muruzábal MJ; Gómez Casares MT; Alsar MJ; Conde E; Iriondo A; Garijo J; Richard C; Baro J; Aguado JM
Enferm Infecc Microbiol Clin; 1990 Oct; 8(8):490-5. PubMed ID: 2095260
[TBL] [Abstract][Full Text] [Related]
30. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
DeJace P; Klastersky J
Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
[TBL] [Abstract][Full Text] [Related]
31. Tobramycin and cephalothin for treatment of suspected sepsis in neutropenic children with cancer.
Cohen JD; Miale TD
J Infect Dis; 1976 Aug; 134 Suppl():S175-7. PubMed ID: 972278
[TBL] [Abstract][Full Text] [Related]
32. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
Klastersky J
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
[TBL] [Abstract][Full Text] [Related]
33. Infection in neutropenic patients with cancer.
Bow EJ
Crit Care Clin; 2013 Jul; 29(3):411-41. PubMed ID: 23830647
[TBL] [Abstract][Full Text] [Related]
34. [Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group].
van Kasteren ME; Stobberingh EE; Janknegt R; Wijnands WJ; van der Meer JW
Ned Tijdschr Geneeskd; 1999 Mar; 143(12):611-7. PubMed ID: 10321287
[TBL] [Abstract][Full Text] [Related]
35. [Antimicrobial therapy of febrile neutropenia--current developments].
Karthaus M; Cornely OA; Südhoff T; Meran J
Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
[TBL] [Abstract][Full Text] [Related]
36. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
Viscoli C; Bruzzi P; Glauser M
Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
[TBL] [Abstract][Full Text] [Related]
37. Survival in neutropenic patients with severe sepsis or septic shock.
Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E
Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615
[TBL] [Abstract][Full Text] [Related]
38. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
39. [Febrile neutropenia in onco-hematology patients hospitalized in Intensive Care Unit].
Saillard C; Sannini A; Chow-Chine L; Blache JL; Brun JP; Mokart D
Bull Cancer; 2015 Apr; 102(4):349-59. PubMed ID: 25799163
[TBL] [Abstract][Full Text] [Related]
40. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?
Karthaus M; Carratalà J; Jürgens H; Ganser A
Chemotherapy; 1998; 44(6):427-35. PubMed ID: 9755304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
